Teva forecasts it will be a “significant period of time” before both criminal and civil proceedings over alleged generic drug price fixing in the US move to trial, in the latest update involving the long-running saga that continues to cast a shadow over the Israeli giant.
“I think it's fair to say that the COVID-19 pandemic in the US has slowed down proceedings in the legal system, and it basically means that on the criminal side,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?